OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Thursday, August 7th MGRN, MEXP, MDIN, CLXN, VRGI

Aug 07, 2008 (M2 PRESSWIRE via COMTEX) -- VRGI | Quote | Chart | News | PowerRating -- Our Stocks to Watch today include Monogram Energy Inc. (OTC: MGRN), Marine Exploration Inc. (OTC: MEXP), Med Gen Inc. (OTCBB: MDIN), CLX Medical Inc. (OTCBB: CLXN), Virogen Inc. (OTC: VRGI)

Visit http://www.otcpicks.com to register for our Daily Market Mover's Digest Newsletter and Email Stock Watch Alerts.

MONOGRAM ENERGY INCORPORATED (OTC: MGRN)

Detailed Quote: www.otcpicks.com/quotes/MGRN.php

Company Profile: www.otcpicks.com/monogram-energy/monogram-energy.htm

Monogram Energy, Inc. is an independent energy company engaged in the acquisition, development, and exploitation of oil and gas properties. The company specializes in acquiring oil & gas leases with proven reserves that have the potential for increased production.

MGRN News:

August 7 - Monogram Energy, Inc. Negotiates New Lease

Monogram Energy, Inc. (OTC: MGRN | Quote | Chart | News | PowerRating) announced that it has entered into negotiations for an additional oil lease located in Navarro County, Texas. Monogram is partnering with another company on this venture, as they have a workover rig which will allow Monogram immediate access to the wells located on the lease.

Mr. Billy King, Chief Executive Officer of Monogram Energy, Inc., stated, "We want to stay aggressive with our acquisition program, as we feel this gives us the best opportunity for long term success."

Mr. King became interested in the production of oil & gas during his ten years of employment as an attorney for the Halliburton Company, and with his representation of independent oil companies during his years as a private practitioner. Monogram Energy's goal is to maintain a high risk/reward profile, thereby enabling them to return the most value to its shareholders.

MARINE EXPLORATION INCORPORATED (OTC: MEXP)

Detailed Quote: www.otcpicks.com/quotes/MEXP.php

Company Profile: www.otcpicks.com/marine-exploration/marine-exploration-2.htm

Marine Exploration, Inc., a development stage company, engages in marine treasure hunting expeditions. It involves in the exploration and recovery of deep-ocean shipwrecks, including the marketing, sale, and distribution of recovered artifacts, replicas, merchandise, and books through various retail and wholesale sales channels. The company was incorporated in 1996 as Jenkon International, Inc. and changed its name to Multimedia K.I.D., Inc. in 1999. Later, it changed its name to SYCO, Inc. in 2006; and to Marine Exploration, Inc. in 2007. The company is based in Denver, Colorado.

MEXP News:

August 5 - Marine Exploration Inc. Acquires Ship

Marine Exploration, Inc. (OTC: MEXP | Quote | Chart | News | PowerRating) announced that it has executed a bill of sale acquiring the Ocean Lady, a 128 foot, 252 ton research vessel. The Ocean Lady, outfitted to the specifications of Burt Webber of Hispaniola Ventures, Marine's joint venture partner, is docked at Jones Boatyard Miami.

MED GEN INCORPORATED (OTCBB: MDIN | Quote | Chart | News | PowerRating) "Up 100.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/MDIN.php

Med Gen Inc., in business since 1996, manufactures and markets specialty products using its proprietary delivery system, Spray's the Way ("STW"). It is best known for producing the world's first patented liquid spray snoring relief formula, Snorenz . Since its existence, Med Gen has continued to develop its STW technology, introducing Good Nights Sleep , the UnDiet system and GOOD NIGHTS SLEEP Sleep Strips into its family of brands. FabULust, the company's newest product, a female sexual stimulant, has been launched in test markets throughout the country. While STW technology is mainly used, the company also produces other products that deal with common health issues using other delivery systems. The company markets its products to distributors, direct sales via the company web site and direct to consumer television, radio and print advertising. The company also distributes its brands internationally under various private labels or existing names. The Company also offers specialty financial and investment services through its Financial Services division, to small emerging public companies.

MDIN News:

August 7 - China Emerging as a Major Customer for Med Gen Products

Med Gen Inc. (OTCBB: MDIN | Quote | Chart | News | PowerRating) ("MDIN"), manufacturers of nationally branded OTC healthier life products and specialty financial services, reports that the documentation approving the shipment of Snorenz has been completed. Snorenz will be shipped under an agreement with its distributor, Sonergy , under a Sonergy-Snorenz label.

Chinese shipments will commence within 90 days to an estimated 48,000 distributors that form a network marketing company in China, which now handles Sonergy dietary supplements and other Sonergy products. Sonergy is a manufacturer of Dietary Supplements, Nutritional Water and Cosmetics.

CLX MEDICAL INCORPORATED (OTCBB: CLXN | Quote | Chart | News | PowerRating) "Up 50.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/CLXN.php

CLX Investment Company, Inc. is a principal investment firm specializing in acquiring developing businesses. The firm was formerly known as CLX Energy, Inc. CLX Investment Company Inc. was founded in 1977 and is based in Temecula, California.

CLXN News:

August 7 - CLX Medical, Inc. Announces Results of Meetings at AACC Annual Meeting and Clinical Lab Expo

Master Distributor for the European Market Expected to Be Announced Shortly; Terms and Closing Schedule for Additional Acquisition in the Medical Diagnostic Testing Market Was Also Agreed Upon

CLX Medical, Inc. (OTCBB: CLXN), which is focused on the launch and distribution of unique medical diagnostic testing products, today updated shareholders on its successful attendance at the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo held last week at in Washington, DC.

Among the more significant accomplishments achieved by CLX Medical management at the event was reaching agreement with a major European distributor to serve as the sole importer of CLX's subsidiary products into the European market. In the meetings with the targeted master distributor, a marketing strategy for European sales was established, and CLX expects to announce a Letter of Intent with the distributor in the next several days. The name of the company will also be announced at that time.

CLX Medical also met with the current owner and the manufacturer of an additional medical diagnostic testing product, which CLX expects to acquire in the near term. The two companies have reached agreement on acquisition terms and on a timeline for definitive agreement and the close of the acquisition. CLX expects to identify the product, the market opportunity presented by this acquisition and details of its launch plan within the next two weeks.

The AACC event was held from July 27-31 at the Walter E. Washington Convention Center in Washington, DC. AACC's Clinical Lab Expo, the largest gathering of laboratory industry companies in the world, was anticipated to include 1,800 booths and 650 exhibitors. The Expo allows visitors to see and speak to world-leading companies about the latest developments in laboratory medicine. More information on the event can be found at:

www.aacc.org/EVENTS/ANN_MEET/Pages/default.aspx.

"Everything we had hoped to accomplish at the AACC Annual Meeting and Clinical Lab Expo was achieved, and we look forward to providing the details of our agreement with our master distributor for Europe in the next several days and of our anticipated acquisition target shortly thereafter," commented Vera Leonard, chief executive officer of CLX Medical. "Our attendance at the event was more than worth the time we spent there, and we hope that CLX shareholders will follow our new releases closely as we follow-up with the details of each of these agreements."

VIROGEN INCORPORATED (OTC: VRGI | Quote | Chart | News | PowerRating) "Up 63.16% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/VRGI.php

Virogen, Inc. is the developer and patent holder of a revolutionary vaccine to combat Newcastle disease, a deadly disease that kills chickens worldwide.

VRGI News:

August 6 - Virogen's Distributor Signs Multi-Million Dollar Contracts

Virogen, Inc. (OTC: VRGI | Quote | Chart | News | PowerRating) announced that its distributor has signed contracts with the largest poultry producers in Egypt and Saudi Arabia. Vaccine sales of two million in the first year and four to five million thereafter are projected based upon these contracts alone.

While poultry vaccines are now available in the form of a spray or nasal inhalant, the product developed by Virogen is 2000 times more potent than those now on the market. It is injected directly into the chicken embryo and provides immunity up to ten weeks, with the average time to market being six weeks. The trend in protection of livestock is to administer vaccines in-ovo wherever possible, and the Virogen vaccine (inovo-immune) not only fulfills that preference, but is also far cheaper to produce, more effective, and far less expensive to the purchaser than conventional vaccines.

Newcastle is a deadly disease which can decimate entire flocks should an outbreak occur. The most recent outbreak, which occurred in California in the 90s, cost the government over $300 million and the loss of hundreds of thousands of birds. Another outbreak occurred in Texas with similar results. Most outbreaks worldwide go unreported. Fully 85% of the worldwide market resides outside of the United States with Asia, South America, and the Middle East comprising the largest markets. The company has made the strategic decision to concentrate its resources on these world markets in order to maximize revenues and market penetration in the shortest possible time frames. These markets are experiencing rapid growth as protein consumption abroad is rising at a far more rapid rate than in the US domestic market.

To position itself to reach the worldwide market, the company entered into a manufacturing agreement with Romvac, a company headquartered in Bucharest, Romania that has been manufacturing veterinary medicines since 1978. Romvac is an established, well respected manufacturer and meets the highest standards available for a certified distributor. Manufacturing within a European Union member country allows access to the EU market and allows the company to fast track registration of the vaccine in countries worldwide in the shortest possible time. This strategy has not only been cost effective, but has also shortened the commercialization to world markets by several years.

Paul Hogan, CEO of Virogen, Inc., notes that "Every production bird in the world is required to be vaccinated, and since Virogen's vaccine is the only in-ovo patent-protected product on the market, the company anticipates it will capture this exclusive market for several years. With approximately 45 billion birds being produced annually outside of the United States, and consumption growing by close to 30% per annum and expected to increase further, one can anticipate the revenue opportunity for this vaccine is in the tens of millions over the product life cycle."

ABOUT OTCPICKS.COM

OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Profile Research Reports authored by our financial writers. We publish a daily Newsletter to subscribers, and we publish our Daily Market Movers Digest which is sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To feature a company on our web site or in our daily Newsletter or Market Mover's Digest, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The OTCPicks.com employees are NOT Registered as an Investment Advisor in any jurisdiction whatsoever.

Release of Liability:Through use of this website viewing or using you agree to hold OTCPicks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. OTCPicks.com has received fifty thousand free trading shares from a non-controlling third party (Microcap Management) for MGRN advertising and promotional services. OTCPicks.com has received forty thousand free trading shares from a third party for MEXP advertising and promotional services. For a complete list of disclosures go to http://www.otcpicks.com/disclosure-details.htm. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCPicks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCPicks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. OTCPicks.com and its affiliates are not registered investment advisors or a broker dealers. OTCPicks.com has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor's sole risk. OTCPicks.com also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. OTCPicks.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through OTCPicks.com. OTCPicks.com owners may or may not hold positions in the companies that are profiled.

The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results.

Third Party Web Sites and Information:

OTCPicks.com and newsletter may provide hyperlinks to third party websites or access to third party content. OTCPicks.com does not control, endorse, or guarantee content found in such sites. You agree that OTCPicks.com is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that OTCPicks.com shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.

CONTACT: Brian Dean, Publisher, OTCPicks.com Tel: +1 972 546 3740 e-mail: publisher@otcpicks.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index